Best Biotechnology Company Hayward Near Me

4worldlovers:
Eikon is a pioneering drug discovery and development company that leverages superior engineering and high-performance computing to analyze single molecule protein behavior in living cells. We are engineering a battery of innovative tools and technologies for biological exploration in drug discovery and beyond.

We believe the future of drug discovery will incorporate live cell imaging of single protein movement in cells. Eikon is pioneering a new method of drug discovery based on tracking and measuring these movements of individual proteins in living cells. The ability to assess protein dynamics will reveal novel biological mechanisms of action, providing new therapeutic approaches that will address both existing and novel drug targets. These insights will form the basis for innovative new therapies for grievous illness.

4worldlovers: We provide safe, natural and proven technologies that remove major contaminants from water. Communities around the world use our water technologies to save up to 50% in costs while reducing their environmental footprint.

Our solutions for wastewater treatment and reuse reliably meet discharge limits, lower costs by an average of 30-50%, and recover valuable energy and chemicals. Welcome to the future of wastewater treatment — today.

Our radically simple approach to bioproduction helps drive attractive margins that can be shared among licensing partners, customers and manufacturers.

Partnerships are the core of our R&D. Learn about our capabilities and how a partnership with Microvi could make a difference for your organization.

For more than a decade, Microvi has been part of a movement to deliver cutting-edge technologies to the people who need them most.

4worldlovers: Pulse Biosciences pioneers in the research, design and production of our patented Nanosecond Pulsed Field Ablation (nsPFA) technology for use in high impact areas of healthcare. We are currently focused on applying this technology within cardiology. We believe there may be several applications in cardiology for nsPFA, including as a potential treatment of atrial fibrillation.


Nanosecond Pulsed Field Ablation (nsPFA) energy is a novel technology that has the potential to not only help patients with atrial fibrillation but also patients across many different therapy areas.


Pulse Biosciences' proprietary Nanosecond Pulsed Field AblationTM (nsPFATM) Technology was recently featured in multiple presentations at the 2023 Heart Rhythm Society Meeting (HRS 2023). These presentations demonstrated preclinical evidence on the use of nsPFA energy for the treatment of heart rhythm disorders. “This data is a validation of the quality of the preclinical work completed with our physician collaborators and our opportunity to advance the treatment of atrial fibrillation. We are excited to continue on the path towards first in-human clinical use," said Kevin Danahy, Chief Executive Officer.


Pulse Biosciences announces poster presentation at the 2023 AF Symposium describing the novel use of Nanosecond Pulsed Field Ablation (nsPFA) technology in cardiac ablation for the treatment of arrhythmias. View press release.

Our proprietary Nanosecond Pulsed Field Ablation (nsPFA) technology delivers nanosecond pulses of electrical energy to nonthermally clear cells while sparing adjacent noncellular tissue. nsPFA energy is delivered from the powerful and versatile nsPFA generator platform. The nsPFA platform was developed to be capable of connecting to multiple types of applicators from superficial to surgical to catheter-based therapies. Our system has already been used to treat over 6,000 patients safely and effectively outside of Cardiology.

These ultrafast electrical energy pulses have pulse durations from billionths up to a millionth of a second. When applied to targeted tissue, nsPFA energy pulses enter cells and alter the function of the internal cellular organelles, including the mitochondria and endoplasmic reticulum. The cascade of intracellular disruption leads to regulated cell death (RCD). RCD is a process exhibited by cells in the human body when they undergo stress and are unable to restore cellular homeostasis.

Pulse Biosciences has brought to market the first commercial product to harness the distinctive advantages of nsPFA technology.

Unlike thermal technologies, nsPFA energy directly impacts cellular structures while sparing non cellular tissue

NsPFA energy pulses initiate nanopores in cellular membranes that allow ions, such as calcium, to move within the cell

Triggers a cascade of intracellular disruption that stresses vital cell organelles

Breakdown of vital cell organelles leads to regulated cell death (RCD)

Pulse Biosciences is the inventor and sole proprietor of Nanosecond Pulsed Field Ablation (nsPFA) technology. We are committed to health innovation that has the potential to improve and extend the lives of patients. Our proprietary Nanosecond Pulsed Field Ablation technology delivers nanosecond pulses of electrical energy to nonthermally clear cells while sparing adjacent noncellular tissue.

4worldlovers:
We believe in PREMIUM QUALITY, NOT PREMIUM PRICE. We believe that all researchers deserve access to fast, high quality, and economical services for their work.